ArticleBMC veterinary research2026
Preliminary investigation on the seroprevalence and co-exposure of Brucella spp. and Mycobacterium avium subsp. paratuberculosis in dromedary camels from the Eastern Province of Saudi Arabia.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBrucellosis and paratuberculosis are zoonotic pathogens that affect animal and human health worldwide. Although both diseases are endemic in Saudi Arabia, little is known about their concurrent and potential epidemiological or immunological interactions in dromedary camels. This study investigated the serological evidence and associated risk factors of single and mixed infections with Brucella spp. and Mycobacterium avium subspecies paratuberculosis (MAP) in camels from the Eastern Province of Saudi Arabia. A total of 320 serum samples were collected from 253 female and 67 male camels and screened for Brucella antibodies using the Rose Bengal Test and competitive ELISA, and for MAP antibodies using indirect ELISA.
resultsThe overall seroprevalence of brucellosis and paratuberculosis was 12.5% and 15.3%, respectively, with 2.2% of camels showing serological evidence of co-infection. Brucellosis was most prevalent in Hamra camels (15.4%), while Sawahli camels had the highest MAP seropositivity (20.0%). Although female (11.5%) camels showed numerically higher brucellosis seroprevalence than males (6.0%), this difference was not statistically significant. On the other hand, mixed infection was significantly more frequent in males (6.0%) than females (1.2%) (p = 0.04). Older camels (≥ 6 years) were at higher risk of brucellosis seropositivity (12.4%) than younger animals (< 6 years, 5.8%) (p = 0.03). Pregnant females had a significant (p = 0.02) increase in MAP prevalence (22.2%) compared to non-pregnant females (10.6%).
conclusionsThese findings highlight a notable overlap in the serological profiles of Brucella and MAP infections, suggesting shared risk factors or possible immune cross-modulation in camels. The coexistence of anti-Brucella antibodies in approximately 15% of MAP-seropositive camels underscores the need to reconsider diagnostic and control strategies under a One Health framework. Understanding such interactions could improve surveillance programs and inform targeted interventions for the camel industry in Saudi Arabia and other endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.